Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mianserin and Imagery Rehearsal Therapy for Sleep in Refugees with PTSD
NCT02761161Phase 4Completed
- Sponsor
- Mental Health Services - Capital Region of Denmark
- Start
- Mar 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mianserin in post-traumatic stress disorder (PTSD) (4 arms), sponsored by Mental Health Services - Capital Region of Denmark. Primary endpoint: Pittsburgh Sleep Quality Index. Started Mar 2016; status: completed.
02
Drugs
mianserin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02761161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761161.